Gladius Capital Management LP Bio Rad Laboratories, Inc. Transaction History
Gladius Capital Management LP
- $166 Million
- Q3 2024
A detailed history of Gladius Capital Management LP transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Gladius Capital Management LP holds 96 shares of BIO stock, worth $33,069. This represents 0.02% of its overall portfolio holdings.
Number of Shares
96
Previous 96
-0.0%
Holding current value
$33,069
Previous $32,000
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding BIO
# of Institutions
456Shares Held
18.2MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$657 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$534 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$449 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$374 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$246 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.49B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...